ID   HIF1A_BOVIN             Reviewed;         823 AA.
AC   Q9XTA5;
DT   03-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   07-APR-2021, entry version 163.
DE   RecName: Full=Hypoxia-inducible factor 1-alpha;
DE            Short=HIF-1-alpha;
DE            Short=HIF1-alpha;
GN   Name=HIF1A;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Artery;
RX   PubMed=10320777; DOI=10.1016/s0167-4781(99)00048-2;
RA   Hara S., Kobayashi C., Imura N.;
RT   "Molecular cloning of cDNAs encoding hypoxia-inducible factor (HIF)-1alpha
RT   and -2alpha of bovine arterial endothelial cells.";
RL   Biochim. Biophys. Acta 1445:237-243(1999).
CC   -!- FUNCTION: Functions as a master transcriptional regulator of the
CC       adaptive response to hypoxia. Under hypoxic conditions, activates the
CC       transcription of over 40 genes, including erythropoietin, glucose
CC       transporters, glycolytic enzymes, vascular endothelial growth factor,
CC       HILPDA, and other genes whose protein products increase oxygen delivery
CC       or facilitate metabolic adaptation to hypoxia. Plays an essential role
CC       in embryonic vascularization, tumor angiogenesis and pathophysiology of
CC       ischemic disease. Heterodimerizes with ARNT; heterodimer binds to core
CC       DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of
CC       target gene promoters (By similarity). Activation requires recruitment
CC       of transcriptional coactivators such as CREBBP and EP300. Activity is
CC       enhanced by interaction with both, NCOA1 or NCOA2. Interaction with
CC       redox regulatory protein APEX seems to activate CTAD and potentiates
CC       activation by NCOA1 and CREBBP. Involved in the axonal distribution and
CC       transport of mitochondria in neurons during hypoxia (By similarity).
CC       {ECO:0000250, ECO:0000250|UniProtKB:Q61221}.
CC   -!- ACTIVITY REGULATION: Induced by reactive oxygen species (ROS).
CC       {ECO:0000250|UniProtKB:Q16665}.
CC   -!- SUBUNIT: Interacts with COPS5 subunit of COP9 signalosome complex,
CC       leading to the regulation of its stability. Interacts with the ARNT;
CC       forms a heterodimer that binds core DNA sequence 5'-TACGTG-3' within
CC       the hypoxia response element (HRE) of target gene promoters (By
CC       similarity). Interacts with NCOA1, NCOA2, APEX, HSP90 and TSGA10.
CC       Interacts with VHL which docks HFA1 to the E3 ubiquitin ligase complex
CC       for subsequent destruction. Interaction, via the ODD domain, with the
CC       beta domain of VHLL, protects HIF1A from destruction by competing
CC       against the destructive targeting initiated by VHL. Interacts with RORA
CC       (via the DNA binding domain); the interaction enhances HIF1A
CC       transcription under hypoxia through increasing protein stability.
CC       Interaction with PSMA7 inhibits the transactivation activity of HIF1A
CC       under both normoxic and hypoxia-mimicking conditions. Interacts with
CC       USP20. Interacts with RACK1; promotes HIF1A ubiquitination and
CC       proteasome-mediated degradation. Interacts with EP300 (via TAZ-type 1
CC       domain); the interaction is stimulated in response to hypoxia and
CC       inhibited by CITED2. Interacts with CREBBP (via TAZ-type 1 domain).
CC       Interacts (via N-terminus) with USP19. Interacts with SIRT2. Interacts
CC       (deacetylated form) with EGLN1. Interacts with RWDD3; the interaction
CC       enhances HIF1A sumoylation. Interacts with HIF3A. Interacts with
CC       CBFA2T3. Interacts with HSP90AA1 and HSP90AB1. Interacts with DCUN1D1;
CC       this interaction increases the interaction between VHL and DCUN1D1 (By
CC       similarity). {ECO:0000250|UniProtKB:Q16665,
CC       ECO:0000250|UniProtKB:Q61221}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q16665}. Nucleus
CC       {ECO:0000250|UniProtKB:Q61221}. Note=Colocalizes with HIF3A in the
CC       nucleus and speckles (By similarity). Cytoplasmic in normoxia, nuclear
CC       translocation in response to hypoxia (By similarity).
CC       {ECO:0000250|UniProtKB:Q16665, ECO:0000250|UniProtKB:Q61221}.
CC   -!- DOMAIN: Contains two independent C-terminal transactivation domains,
CC       NTAD and CTAD, which function synergistically. Their transcriptional
CC       activity is repressed by an intervening inhibitory domain (ID) (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: S-nitrosylation of Cys-797 may be responsible for increased
CC       recruitment of p300 coactivator necessary for transcriptional activity
CC       of HIF-1 complex. {ECO:0000250}.
CC   -!- PTM: Acetylation of Lys-532 by ARD1 increases interaction with VHL and
CC       stimulates subsequent proteasomal degradation. Deacetylation of Lys-706
CC       by SIRT2 increases its interaction with and hydroxylation by EGLN1
CC       thereby inactivating HIF1A activity by inducing its proteasomal
CC       degradation (By similarity). {ECO:0000250}.
CC   -!- PTM: Requires phosphorylation for DNA-binding. Phosphorylation at Ser-
CC       247 by CSNK1D/CK1 represses kinase activity and impairs ARNT binding.
CC       Phosphorylation by GSK3-beta and PLK3 promote degradation by the
CC       proteasome (By similarity). {ECO:0000250}.
CC   -!- PTM: The iron and 2-oxoglutarate dependent 3-hydroxylation of
CC       asparagine is (S) stereospecific within HIF CTAD domains.
CC       {ECO:0000250}.
CC   -!- PTM: Sumoylated; with SUMO1 under hypoxia. Sumoylation is enhanced
CC       through interaction with RWDD3. Both sumoylation and desumoylation seem
CC       to be involved in the regulation of its stability during hypoxia.
CC       Sumoylation can promote either its stabilization or its VHL-dependent
CC       degradation by promoting hydroxyproline-independent HIF1A-VHL complex
CC       binding, thus leading to HIF1A ubiquitination and proteasomal
CC       degradation. Desumoylation by SENP1 increases its stability amd
CC       transcriptional activity. There is a disaccord between various
CC       publications on the effect of sumoylation and desumoylation on its
CC       stability and transcriptional activity (By similarity). {ECO:0000250}.
CC   -!- PTM: In normoxia, is hydroxylated on Pro-402 and Pro-564 in the oxygen-
CC       dependent degradation domain (ODD) by EGLN1/PHD2 and EGLN2/PHD1.
CC       EGLN3/PHD3 has also been shown to hydroxylate Pro-564. The hydroxylated
CC       prolines promote interaction with VHL, initiating rapid ubiquitination
CC       and subsequent proteasomal degradation. Deubiquitinated by USP20. Under
CC       hypoxia, proline hydroxylation is impaired and ubiquitination is
CC       attenuated, resulting in stabilization (By similarity). In normoxia, is
CC       hydroxylated on Asn-800 by HIF1AN, thus abrogating interaction with
CC       CREBBP and EP300 and preventing transcriptional activation. Repressed
CC       by iron ion, via Fe(2+) prolyl hydroxylase (PHD) enzymes-mediated
CC       hydroxylation and subsequent proteasomal degradation.
CC       {ECO:0000250|UniProtKB:Q16665}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB018398; BAA78675.1; -; mRNA.
DR   SMR; Q9XTA5; -.
DR   STRING; 9913.ENSBTAP00000027885; -.
DR   PaxDb; Q9XTA5; -.
DR   PRIDE; Q9XTA5; -.
DR   eggNOG; KOG3558; Eukaryota.
DR   InParanoid; Q9XTA5; -.
DR   Proteomes; UP000009136; Unplaced.
DR   GO; GO:1904115; C:axon cytoplasm; IEA:GOC.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0035035; F:histone acetyltransferase binding; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0019896; P:axonal transport of mitochondrion; ISS:UniProtKB.
DR   GO; GO:0071456; P:cellular response to hypoxia; ISS:UniProtKB.
DR   GO; GO:1900017; P:positive regulation of cytokine production involved in inflammatory response; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0061419; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0010575; P:positive regulation of vascular endothelial growth factor production; ISS:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0006110; P:regulation of glycolytic process; ISS:UniProtKB.
DR   GO; GO:2000434; P:regulation of protein neddylation; ISS:UniProtKB.
DR   GO; GO:0001666; P:response to hypoxia; ISS:UniProtKB.
DR   GO; GO:0000302; P:response to reactive oxygen species; ISS:UniProtKB.
DR   CDD; cd00130; PAS; 2.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR001321; HIF-1_alpha.
DR   InterPro; IPR014887; HIF-1_TAD_C.
DR   InterPro; IPR021537; HIF_alpha_subunit.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR013767; PAS_fold.
DR   InterPro; IPR013655; PAS_fold_3.
DR   Pfam; PF11413; HIF-1; 1.
DR   Pfam; PF08778; HIF-1a_CTAD; 1.
DR   Pfam; PF00989; PAS; 1.
DR   Pfam; PF08447; PAS_3; 1.
DR   PRINTS; PR01080; HYPOXIAIF1A.
DR   SMART; SM00353; HLH; 1.
DR   SMART; SM00086; PAC; 1.
DR   SMART; SM00091; PAS; 2.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   SUPFAM; SSF55785; SSF55785; 2.
DR   TIGRFAMs; TIGR00229; sensory_box; 2.
DR   PROSITE; PS50888; BHLH; 1.
DR   PROSITE; PS50112; PAS; 2.
PE   2: Evidence at transcript level;
KW   Acetylation; Activator; Cytoplasm; DNA-binding; Hydroxylation;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   S-nitrosylation; Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN           1..823
FT                   /note="Hypoxia-inducible factor 1-alpha"
FT                   /id="PRO_0000127219"
FT   DOMAIN          17..70
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   DOMAIN          85..158
FT                   /note="PAS 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   DOMAIN          228..298
FT                   /note="PAS 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   DOMAIN          302..345
FT                   /note="PAC"
FT   REGION          1..401
FT                   /note="Interaction with TSGA10"
FT                   /evidence="ECO:0000250"
FT   REGION          21..30
FT                   /note="DNA-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q61221"
FT   REGION          170..191
FT                   /note="Required for heterodimer formation with ARNT"
FT                   /evidence="ECO:0000250|UniProtKB:Q61221"
FT   REGION          401..600
FT                   /note="ODD"
FT   REGION          531..575
FT                   /note="NTAD"
FT   REGION          576..782
FT                   /note="ID"
FT   REGION          783..823
FT                   /note="CTAD"
FT   MOTIF           715..721
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         247
FT                   /note="Phosphoserine; by CK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q16665"
FT   MOD_RES         402
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         532
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q16665"
FT   MOD_RES         551
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:Q16665"
FT   MOD_RES         555
FT                   /note="Phosphothreonine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:Q16665"
FT   MOD_RES         564
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:Q16665"
FT   MOD_RES         576
FT                   /note="Phosphoserine; by PLK3"
FT                   /evidence="ECO:0000250|UniProtKB:Q16665"
FT   MOD_RES         589
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:Q16665"
FT   MOD_RES         654
FT                   /note="Phosphoserine; by PLK3"
FT                   /evidence="ECO:0000250|UniProtKB:Q16665"
FT   MOD_RES         706
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16665"
FT   MOD_RES         797
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16665"
FT   MOD_RES         800
FT                   /note="(3S)-3-hydroxyasparagine"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        532
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q16665"
FT   CROSSLNK        538
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16665"
FT   CROSSLNK        547
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16665"
SQ   SEQUENCE   823 AA;  92128 MW;  12674E467A61B1A1 CRC64;
     MEGAGGANDK KKISSERRKE KSRDAARSRR SKESEVFYEL AHQLPLPHNV SSHLDKASVM
     RLTISYLRVR KLLDAGDLDI EDEMKAQMNC FYLKALDGFV MVLTDDGDMI YISDNVNKYM
     GLTQFELTGH SVFDFTHPCD HEEMREMLTH RNGLVKKGKE QNTQRSFFLR MKCTLTSRGR
     TMNIKSATWK VLHCTGHIHV YDTNSNQSQC GYKKPPMTCL VLICEPIPHP SNIEIPLDSK
     TFLSRHSLDM KFSYCDERIT ELMGYEPEEL LGRSIYEYYH ALDSDHLTKT HHDMFTKGQV
     TTGQYRMLAK RGGYVWIETQ ATVIYNTKNS QPQCIVCVNY VVSGIIQHDL IFSLQQTECV
     LKPVESSDMK MTQLFTKVES EDTSSLFDKL KKEPDALTLL APAAGDTIIS LDFGSNDTET
     DDQQLEEVPL YNDVMLPSSN EKLQNINLAM SPLPASETPK PLRSSADPAL NQEVALKLEP
     NPESLELSFT MPQIQDQPAS PSDGSTRQSS PEPNSPSEYC FDVDSDMVNE FKLELVEKLF
     AEDTEAKNPF STQDTDLDLE MLAPYIPMDD DFQLRSFDQL SPLENSSTSP QSASTNTVFQ
     PTQMQKPPIA TVTTTATSDE LKTVTKDGME DIKILIAFPS PPHVPKEPPC ATTSPYSDTG
     SRTASPNRAG KGVIEQTEKS HPRSPNVLSV ALSQRTTAPE EELNPKILAL QNAQRKRKIE
     HDGSLFQAVG IGTLLQQPDD RATTTSLSWK RVKGCKSSEQ NGMEQKTIIL IPSDLACRLL
     GQSMDESGLP QLTSYDCEVN APIQGSRNLL QGEELLRALD QVN
//
